ARTICLE | Clinical News
ThGRF (TH 9507): Began Phase II trial
December 3, 2001 8:00 AM UTC
Theratechnologies Inc. (TSE:TH), Saint-Laurent, Quebec Product: ThGRF (TH 9507) Business: Metabolic Therapeutic category: Hormone replacement Target: Growth hormone releasing hormone receptor Descri...